AzurBio
Empowering biopharma companies through strategic consulting and tailored solutions to shape and execute European expansion.
Europe. A fantastic opportunity for biopharmaceutical companies.
EU is the
2 nd*
largest market globally
for prescription medicines
*22.7% of world pharmaceutical prescription sales. Source: EFPIA, IQVIA MIDAS, 2025.
Europe. A challenging and complex market to address.
Europe is Not a country
- Multiple regulatory and market access environments vs the US
- Market differences between individual European countries
Need Expertise and focused efforts to
- Understand Europe as a whole & as individual markets
- Adopting a strategic approach to market prioritization
Our Solutions.
We provide innovative solutions to enter the EU market by maximizing flexibility and minimizing operational burden, from registration through to commercialization.
Expand to Europe
A unique partnership model that goes beyond traditional full outsourcing or licensing agreements.
Unlock France
Meeting France’s Exploitant requirements efficiently & compliantly.
Consulting
Strategic guidance, tailored solutions, and regulatory services for life sciences products (pharmaceuticals, medical devices & others) – from early development to market launch and beyond.
Our Clients. Innovators in rare or serious diseases.
Our Mission in motion.
AzurBio.
The partner of choice for biopharmas.
France
Paris (Headquarter)
Nice
Zug
United States
Boston
New York
Our Strategic Committee. Seasoned Industry Experts.
-
Chairman, Founder & CEO at AzurBio
-
Former VP General Manager EU at Alnylam
-
Health Industry Partner at CMI
-
Former SVP Head of Global Regulatory Affairs at Ipsen
-
Former General Manager & Strategic Senior Pharma Consultant
Our Affiliations.
